XML 43 R30.htm IDEA: XBRL DOCUMENT v3.20.4
Business Segment Information
12 Months Ended
Dec. 31, 2020
Business Segment Information  
Business Segment Information

22.   Business Segment Information

The Company has three reportable segments, BSI Life Science, BSI NANO and BEST, as discussed in Note 1 to the consolidated financial statements.

Selected reportable segment information is presented below (in millions):

    

2020

    

2019

    

2018

Revenue:

BSI Life Science

$

1,253.9

$

1,244.9

$

1,138.9

BSI NANO

556.1

632.7

568.1

BEST

189.5

209.9

194.8

Eliminations (a)

(12.0)

(14.9)

(6.2)

Total revenue

$

1,987.5

$

2,072.6

$

1,895.6

Operating Income:

BSI Life Science

$

273.8

$

290.3

$

244.0

BSI NANO

23.6

40.4

48.4

BEST

6.2

16.4

14.5

Corporate, eliminations and other (b)

(55.3)

(46.2)

(44.5)

Total operating income

$

248.3

$

300.9

$

262.4

(a)   Represents product and service revenue between reportable segments.

(b)   Represents corporate costs and eliminations not allocated to the reportable segments.

Total assets by segment are as follows (in millions):

    

2020

    

2019

Assets:

BSI Life Science, BSI NANO & Corporate

$

2,964.5

$

2,711.6

BEST

88.7

64.6

Eliminations and other (a)

(4.2)

(4.7)

Total assets

$

3,049.0

$

2,771.5

(a)   Assets not allocated to the reportable segments and eliminations of intercompany transactions.

The Company is unable, without unreasonable effort or expense to disclose the amount of total assets by the BSI Life Science and BSI NANO Segments as well as the Corporate function and further, the Company’s chief operating decision maker does not receive any asset information by operating segment.

Total capital expenditures and depreciation and amortization by segment are presented below (in millions):

    

2020

    

2019

    

2018

Capital Expenditures:

BSI Life Science

$

59.1

$

44.4

$

27.6

BSI NANO

10.6

18.5

11.6

Corporate

17.4

4.7

3.6

BEST

10.1

5.4

6.4

Total capital expenditures

$

97.2

$

73.0

$

49.2

Depreciation and Amortization:

BSI Life Science

$

35.0

$

30.5

$

24.0

BSI NANO

35.7

35.9

32.2

Corporate

4.0

3.8

4.0

BEST

5.7

5.4

4.7

Total depreciation and amortization

$

80.4

$

75.6

$

64.9

Revenue and long-lived assets (including property, plant and equipment, net and operating lease right of use assets) by geographical area are as follows (in millions):

    

2020

    

2019

    

2018

Revenue:

United States

$

455.9

$

529.8

$

489.4

Germany

244.9

213.6

201.1

Rest of Europe

519.8

505.2

500.2

Asia Pacific

629.1

651.0

549.2

Other

137.8

173.0

155.7

Total revenue

$

1,987.5

$

2,072.6

$

1,895.6

    

2020

    

2019

    

2018

Long-lived assets

United States

$

61.3

$

53.2

$

44.1

Germany

227.8

175.1

137.0

Rest of Europe

144.7

118.3

78.7

Asia Pacific

22.1

16.4

6.3

Other

7.1

8.7

4.5

Total long-lived assets

$

463.0

$

371.7

$

270.6